These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6987307)
1. Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells. Männel DN; Farrar JJ; Mergenhagen SE J Immunol; 1980 Mar; 124(3):1106-10. PubMed ID: 6987307 [TBL] [Abstract][Full Text] [Related]
2. Restoration of LPS responsiveness of C3H/HeJ mouse lymphocytes by microinjection of cytoplasmic factor(s) from LPS-stimulated normal lymphocytes. Eda Y; Ohara J; Watanabe T J Immunol; 1983 Sep; 131(3):1294-9. PubMed ID: 6604094 [TBL] [Abstract][Full Text] [Related]
3. Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. Moore RN; Oppenheim JJ; Farrar JJ; Carter CS; Waheed A; Shadduck RK J Immunol; 1980 Sep; 125(3):1302-5. PubMed ID: 6774016 [TBL] [Abstract][Full Text] [Related]
4. Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses. Farrar JJ; Simon PL; Koopman WJ; Fuller-Bonar J J Immunol; 1978 Oct; 121(4):1353-60. PubMed ID: 308962 [TBL] [Abstract][Full Text] [Related]
5. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. Farrar WL; Mizel SB; Farrar JJ J Immunol; 1980 Mar; 124(3):1371-7. PubMed ID: 6153680 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor. Drysdale BE; Zacharchuk CM; Shin HS J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164 [TBL] [Abstract][Full Text] [Related]
7. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS. Mizel SB; Oppenheim JJ; Rosentreich DL J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016 [TBL] [Abstract][Full Text] [Related]
8. Association of a low molecular weight helper factor(s) with thymocyte proliferative activity. Koopman WJ; Farrar JJ; Oppenheim JJ; Fuller-Bonar J; Dougherty S J Immunol; 1977 Jul; 119(1):55-60. PubMed ID: 301539 [TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor. Clark-Lewis I; Schrader JW J Immunol; 1982 Jan; 128(1):168-74. PubMed ID: 6976369 [TBL] [Abstract][Full Text] [Related]
10. The purification and quantitation of helper T cell-replacing factors secreted by murine spleen cells activated by concanavalin A. Watson J; Aarden LA; Lefkovits I J Immunol; 1979 Jan; 122(1):209-15. PubMed ID: 310827 [TBL] [Abstract][Full Text] [Related]
11. Autoreactive and alloreactive antibody-forming cells (AFC) following lipopolysaccharide (LPS) activation of normal and memory lymphocytes. McHugh YE; Bonavida B Transplant Proc; 1980 Mar; 12(1):179-87. PubMed ID: 6154354 [No Abstract] [Full Text] [Related]
13. Chemical characterization of macrophage cytotoxicity factor, macrophage migration inhibitory factor, T-helper cell-replacing factor and colony-stimulating factor from culture supernatants of concanavalin A-stimulated murine spleen cells. Hübner L; Kniep EM; Laukel H; Sorg C; Fischer H; Gassel WD; Havemann K; Kickhöfen B; Lohmann-Matthes ML; Schimpl A; Wecker E Immunobiology; 1980 Jul; 157(2):169-78. PubMed ID: 6997190 [TBL] [Abstract][Full Text] [Related]
14. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line. Meltzer MS; Benjamin WR; Farrar JJ J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943 [TBL] [Abstract][Full Text] [Related]
15. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D; Meltzer MS J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562 [TBL] [Abstract][Full Text] [Related]
16. Biochemical relationship between murine immune interferon and a killer cell helper factor. Simon PL; Farrar JJ; Dind PD J Immunol; 1979 Jan; 122(1):127-32. PubMed ID: 84015 [TBL] [Abstract][Full Text] [Related]
17. Partial characterisation of the high and low molecular weight forms of P388D1-derived interleukin 1. Prestidge RL; Koopman WJ; Bennett JC J Cell Biochem; 1984; 26(2):65-73. PubMed ID: 6335509 [TBL] [Abstract][Full Text] [Related]
18. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. Li Y; McGowan P; Hellström I; Hellström KE; Chen L J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929 [TBL] [Abstract][Full Text] [Related]
19. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells. Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648 [TBL] [Abstract][Full Text] [Related]
20. Collaboration between histoincompatible T and B lymphocytes: preferential induction in vivo of antibodies to antigens borne by foreign T cells. Piguet PF; Vassalli P J Immunol; 1981 Oct; 127(4):1304-7. PubMed ID: 7024406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]